Feasibility and safety of tailored dosing schedule for eculizumab based on therapeutic drug monitoring: Lessons from a prospective multicentric study
Christophe Passot(Université de Tours), Philippe Gatault(Centre Hospitalier Universitaire de Tours), Gilles Paintaud(Université de Tours), Cécile Contin‐Bordes(Centre National de la Recherche Scientifique), Betoul Schvartz(Centre Hospitalier Universitaire de Reims), Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), Sophie Caillard(Hôpitaux Universitaires de Strasbourg), Rébecca Sberro‐Soussan(Hôpital Necker-Enfants Malades), David Ternant(Université de Tours), C. Domenger(Centre Hospitalier Universitaire de Poitiers), Dominique Bertrand(Université de Rouen Normandie)
Cited by 15
Related Papers
Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study
|Radiology|2020|472
Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations
|Journal of the American Society of Nephrology|2010|470
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*
|Nephrology Dialysis Transplantation|2017|228
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response
|Immunity|2015|223
Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population
|Kidney International|2000|191